Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 10
Submit an article Journal homepage
91
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma

Osnat Bairey Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
,
Dorit Blickstein Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
,
Pinhas Stark Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
,
Miron Prokocimer Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
,
Hila Magen Nativ Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
,
Ilia Kirgner Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
&
Mati Shaklai Institute of Hematology and Felsenstein Medical Research Center, Rabin Medical Center, Petah Tiqva and Sackler Faculty of Medicine Tel Aviv University Beilinson Campus Tel Aviv Israel
 show all
Pages 1733-1738 | Published online: 01 Jul 2009

Citations (38)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Leonardo Mirandola, Martin J. Cannon, Everardo Cobos, Giovanni Bernardini, Marjorie R. Jenkins, W. Martin Kast & Maurizio Chiriva-Internati. (2011) Cancer Testis Antigens: Novel Biomarkers and Targetable Proteins for Ovarian Cancer. International Reviews of Immunology 30:2-3, pages 127-137.
Read now
Rohit P. Ojha, Lindsey M. Brown, Martha J. Felini, Karan P. Singh & Raymond Thertulien. (2010) Addressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma. Leukemia & Lymphoma 51:9, pages 1754-1757.
Read now
Gui Wei, Zheng Yuping, Wang Jun, Yang Bing & Zhang Qiaohua. (2006) CA125 expression in patients with non-Hodgkin's lymphoma. Leukemia & Lymphoma 47:7, pages 1322-1326.
Read now
Montserrat Batlle, Josep-Maria Ribera, Albert Oriol, Cruz Pastor, José-Luis Mate, Francesc Fernández-Avilés, Alonso Flores, Fuensanta Millá & Evarist Feliu. (2005) Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients. Leukemia & Lymphoma 46:10, pages 1471-1476.
Read now

Articles from other publishers (34)

Md Abedul Haque. 2023. Current Cancer Biomarkers. Current Cancer Biomarkers 195 227 .
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Sofia Cutaia, Mariano Catello Di Donna, Clarissa Filorizzo, Maria Chiara Lisanti, Ugo Randazzo, Luigi Magrin, Raffaella Romano, Tancredi Didier Bazan Russo, Daniel Olive, Salvatore Vieni, Gianni Pantuso, Vito Chiantera, Antonio Russo, Viviana Bazan & Juan Lucio Iovanna. (2022) Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?. Frontiers in Oncology 12.
Crossref
Giovanna Giordano, Elena Ferioli & Alessandro Tafuni. (2022) The Role of Mesothelin Expression in Serous Ovarian Carcinoma: Impacts on Diagnosis, Prognosis, and Therapeutic Targets. Cancers 14:9, pages 2283.
Crossref
Ying Yang, Zhuogang Liu, Guojun Zhang & Hongtao Wang. (2021) A concise prognostic score system for diffuse large B-cell lymphoma: a retrospective study with long-term follow-up. Future Oncology 17:32, pages 4299-4306.
Crossref
Marliyya S. Zayyan. 2020. Tumor Progression and Metastasis. Tumor Progression and Metastasis.
Sandhya Jain, Divya Chauhan, Shalini Rajaram, Bindiya Gupta & Amrita Singh. (2019) Pelvic Lymphoma: An Elusive Diagnosis. Indian Journal of Gynecologic Oncology 17:3.
Crossref
En-Shao Liu, Jyh-Seng Wang & Wen-Chi Yang. (2019) Peritoneal lymphoma with ascites mimicking portal hypertensive ascites. Medicine 98:8, pages e14583.
Crossref
J. Bradford Kline, Shawn Fernando, Erin N. Ross, Luigi Grasso & Nicholas C. Nicolaides. (2018) Tumor-shed antigen CA125 blocks complement-mediated killing via suppression of C1q-antibody binding. European Journal of Immunology 48:11, pages 1872-1882.
Crossref
Braira WahidHamid BashirMuhammad BilalKhansa WahidAleena Sumrin. (2017) Developing a deeper insight into reproductive biomarkers. Clinical and Experimental Reproductive Medicine 44:4, pages 159.
Crossref
Rosemarie Forstner. 2019. MRI and CT of the Female Pelvis. MRI and CT of the Female Pelvis 287 323 .
Shilpa Vijayakumar, Eli Serur, Bahar Bybordi & Nisha Lakhi. (2016) Primary gynecological non-Hodgkin's lymphoma: A differential diagnosis of a pelvic mass. Gynecologic Oncology Reports 18, pages 29-31.
Crossref
Magalí Chahdi Beltrame, Martín De Santibañes, Victoria Ardiles, Oscar Mazza, Juan Pekolj, Eduardo De Santibañes & Rodrigo Sánchez Clariá. (2015) Primary Hepatic Lymphoma: Features of a Puzzling Disease. Journal of Gastrointestinal Cancer 46:2, pages 178-181.
Crossref
Sharyn Katz & Wafik S. El-Deiry. 2015. Systems Biology of Cancer. Systems Biology of Cancer 473 498 .
. 2015. Systems Biology of Cancer. Systems Biology of Cancer 457 517 .
Xiaohua Wu, Dongxiu Li, Liping Liu, Bojun Liu, Hongxia Liang & Bo Yang. (2013) Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer. Archives of Gynecology and Obstetrics 289:6, pages 1309-1314.
Crossref
E. Curakova, M. Genadieva-Dimitrova, J. Misevski, V. Caloska-Ivanova, V. Andreevski, B. Todorovska, U. Isahi, M. Trajkovska, P. Misevska, N. Joksimovic, S. Genadieva-Stavric, S. Antovic & N. Jankulovski. (2014) NonHodgkin's Lymphoma with Peritoneal Localization. Case Reports in Gastrointestinal Medicine 2014, pages 1-8.
Crossref
Miroslava Jankovic & Ninoslav Mitic. (2012) MUC16/CA125 in the Context of Modular Proteins with an Annotated Role in Adhesion-Related Processes: In Silico Analysis. International Journal of Molecular Sciences 13:8, pages 10387-10400.
Crossref
Hong Li & Constantine Gatsonis. (2012) Dynamic optimal strategy for monitoring disease recurrence. Science China Mathematics 55:8, pages 1565-1582.
Crossref
ZHONGQI LI, KETAO JIN, XIONGFEI YU, XIAODONG TENG, HUA ZHOU, YANLI WANG, LISONG TENG & FEILIN CAO. (2011) Extranodal follicular dendritic cell sarcoma in mesentery: A case report. Oncology Letters 2:4, pages 649-652.
Crossref
Yen-Nien Lin, Jen-Wei Chou, Po-Heng Chuang, Ken-Sheng Cheng, Cheng-Yuan Peng & I-Ping Chiang. (2011) Primary Small Intestinal Natural Killer/T Cell Lymphoma Mimicking Tuberculous Peritonitis: Report of a Case and Review of the Literature. Internal Medicine 50:5, pages 515-518.
Crossref
A. GUTIÉRREZ, J. MARTÍNEZ‐SERRA, B. BARCELÓ, A. SAMPOL, L. VIÑAS, G. GONZÁLEZ, M. D. BEA, J. C. AMAT, J. MARTÍN, R. RAMOS, A. BAUTISTA, J. FORTEZA‐REY, J. RODRÍGUEZ & J. BESALDUCH. (2010) Prognostic value of serum CA125 levels in diffuse large B‐cell lymphoma: potential role of a new sex‐ and age‐adjusted reference value. International Journal of Laboratory Hematology 32:6p2, pages 582-589.
Crossref
H. Mehmet Turk, Ahmet Ozet, Mustafa Özturk, Şeref Komurcu, Okan Kuzhan, Fikret Arpaci, Bekir Ozturk & Mukerrem Safali. (2009) Isolated renal relapse of a case with non-Hodgkin’s lymphoma. Medical Oncology 27:2, pages 434-438.
Crossref
Garnet L. Anderson, Martin McIntosh, Lieling Wu, Matt Barnett, Gary Goodman, Jason D. Thorpe, Lindsay Bergan, Mark D. Thornquist, Nathalie Scholler, Nam Kim, Kathy O'Briant, Charles Drescher & Nicole Urban. (2010) Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study. JNCI: Journal of the National Cancer Institute 102:1, pages 26-38.
Crossref
Katsuya Ikuta, Mikihiro Fujiya, Nobuhiro Ueno, Takaaki Hosoki, Kentaro Moriichi, Mitsunori Honda, Yoshihiro Torimoto, Toshiko Yamochi, Hidekazu Ota & Yutaka Kohgo. (2010) Atypical Mucosa-Associated Lymphoid Tissue Lymphoma in the Transverse Colon Associated with Macroglobulinemia. Internal Medicine 49:7, pages 677-682.
Crossref
Gentao Liu, Keith L. Black & John S. Yu. 2009. Stem Cells and Cancer. Stem Cells and Cancer 275 286 .
Carlos Fernández de Larrea, Maria Teresa Cibeira, Rolando Vallansot, Lluís Colomo & Joan Bladé. (2008) Increased Serum Tumor Markers (CA125 and CA15.3) in Primary Plasma Cell Leukemia: A Case Report and Review of the Literature. Clinical Lymphoma and Myeloma 8:5, pages 312-314.
Crossref
W. GuiT. WangJ. Wang, L. Wang, J. He, B. Yang, Z. Zhao, H. Zhang & Q. Zhang. (2018) An Improved Prognostic Parameter for Non-Hodgkin's Lymphoma Based on the Combination of Three Serum Tumor Markers. The International Journal of Biological Markers 23:4, pages 207-213.
Crossref
Nathalie SchollerNicole Urban. (2007) CA125 in ovarian cancer. Biomarkers in Medicine 1:4, pages 513-523.
Crossref
A.M. Abdelmonem, Amany S. Elwakkad, Maysa T. Saleh & Saadia I. Muhammad. (2007) Serum CA125; as a Diagnostic and Prognostic in Pediatric Lymphomas. Journal of Medical Sciences 7:7, pages 1192-1196.
Crossref
Christophe Bonnet, Yves Beguin, Marie-France Fassotte, Laurence Seidel, Françoise Luyckx & Georges Fillet. (2007) Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology 78:5, pages 399-404.
Crossref
Rosemarie Forstner. 2007. MRI and CT of the Female Pelvis. MRI and CT of the Female Pelvis 233 263 .
Amita Chaube, Mallika Tewari, Usha Singh & H.S. Shukla. (2006) CA 125: A potential tumor marker for gallbladder cancer. Journal of Surgical Oncology 93:8, pages 665-669.
Crossref
O. BAIREY & M. SHAKLAI. (2005) Serum CA 125 levels in patients with chronic lymphocytic leukemia. Clinical and Laboratory Haematology 27:1, pages 57-60.
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:1, pages 35-42.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.